Carol Sargeant
Virginia Commonwealth University · 20 works · 5,481 citations · h-index 12
Top works
- Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values
- Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C†
- A lipidomic analysis of nonalcoholic fatty liver disease
- A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #
- The plasma lipidomic signature of nonalcoholic steatohepatitis†‡
- Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
- The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome
- Association Between High-Normal Levels of Alanine Aminotransferase and Risk Factors for Atherogenesis
- Readiness for behaviour change in non‐alcoholic fatty liver disease: implications for multidisciplinary care models
- Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers
- De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients
- 733 A behavioral analysis of nonalcoholic fatty liver disease: implications for the clinician
- O044 : Distinct fecal and plasma bile acid metabolome of microbial origin characterizes human nonalcoholic fatty liver disease (NAFLD)
- 78 The relationship between metabolic functions and liver histology in nonalcoholic steatohepatitis before and after treatment
- Evolution of Serum Atherogenic Risk in Liver Transplant Recipients: Role of Lipoproteins, Metabolic, and Inflammatory Markers
- 1008 Decreased Fecal Microbial Metabolite Enterolactone is a Novel Inflammatory and Oxidative Stress Related Biomarker of Alcoholic Liver Disease
- 934 Nonalcoholic Steatohepatitis (NASH) Worsens the Atherogenic Risk Profile Beyond Obesity: Role of Adiopir and Lipoprotein Abnormalities
- Mo1995 Predictors of Histological Features in Nonalcholic Fatty Liver Disease in Non-Diabetic Subjects
- Mo1019 Adipose Tissue Insulin Resistance and Lipotoxicity Drive Disease Phenotype and Decline in Pancreatic Beta Cell Function in Nonalcoholic Fatty Liver Disease